DUBLIN & COLUMBIA, Md.--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews and a leading provider of connected, intelligence-powered research technology, have entered a definitive partnership agreement to introduce a new ‘research-ready,' connected site network model for clinical trials. The partnership will integrate ICON's global clinical trial solutions and services with Advarra's site CTMSs, eISF, an.